Global Alcoholic Hepatitis Therapeutic Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Alcoholic hepatitis is a kind of liver disease usually affects people who are used to be heavy drinkers. It can cause short and long-term liver damage. Liver is a major organ of body functions to remove poisons such as alcohol from blood. It’s damaged by long time heavy drinking of alcohol. Usually occur in 30% of long- time alcohol drinkers. Asymptomatic steatohepatitis is also as alcoholic hepatitis the term is used to describe the acute onset of symptomatic hepatitis. Symptoms include changes I appetite, dry mouth, yellowing of skin or eyes, weight loss, fever and fatigue. Sometime alcoholic hepatitis could get serious conditions include fluid buildup in the abdomen, confusion or brain fog and bleeding in esophagus or stomach. Treatment for alcoholic hepatitis involves therapies and drinking cessation to ease the sign and symptoms of liver damage. Corticosteroids are the current main treatment for alcoholic hepatitis in patients who do not have contraindication for steroid treatment. Corticosteroids are the medications have shown short-term benefits in increasing survival of certain people suffer with alcoholic hepatitis. Pentoxifylline is recommend to patients who can’t take corticosteroids. Studies indicate that pentoxifylline might not be effective for people with mild alcoholic hepatitis or people who have not respond to steroid treatment.
LPI (LP Information)' newest research report, the “Alcoholic Hepatitis Therapeutic Industry Forecast” looks at past sales and reviews total world Alcoholic Hepatitis Therapeutic sales in 2022, providing a comprehensive analysis by region and market sector of projected Alcoholic Hepatitis Therapeutic sales for 2023 through 2029. With Alcoholic Hepatitis Therapeutic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Alcoholic Hepatitis Therapeutic industry.
This Insight Report provides a comprehensive analysis of the global Alcoholic Hepatitis Therapeutic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Alcoholic Hepatitis Therapeutic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Alcoholic Hepatitis Therapeutic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Alcoholic Hepatitis Therapeutic and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Alcoholic Hepatitis Therapeutic.
The global Alcoholic Hepatitis Therapeutic market size is projected to grow from US$ 2608.5 million in 2022 to US$ 3781.1 million in 2029; it is expected to grow at a CAGR of 5.4% from 2023 to 2029.
The global alcoholic hepatitis therapeutics market is expected to witness a favorable growth during the forecast period. Increasing incidence of liver diseases and high success rate of pipeline drugs are the major factors which increase global alcoholic hepatitis market. Moreover high adoption rate for novel therapeutic products and increasing prevalence of alcoholic liver disease are some other factors that are expected to fuel the demand of global alcoholic hepatitis market. Global alcoholic hepatitis market shows potential to be expanding and lucrative field due to increasing merger and acquisitions among pharmaceutical companies to develop advance therapies for treating liver diseases. Furthermore, increased focus on retaining best quality of life is one the factor contributing to the growth of the market. However increasing health care expenditure, stringent reimbursement policies and high development cost are some factors that might hinder the growth of alcoholic hepatitis therapeutics market in forecast period.
This report presents a comprehensive overview, market shares, and growth opportunities of Alcoholic Hepatitis Therapeutic market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Alcoholic hepatitis is a kind of liver disease usually affects people who are used to be heavy drinkers. It can cause short and long-term liver damage. Liver is a major organ of body functions to remove poisons such as alcohol from blood. It’s damaged by long time heavy drinking of alcohol. Usually occur in 30% of long- time alcohol drinkers. Asymptomatic steatohepatitis is also as alcoholic hepatitis the term is used to describe the acute onset of symptomatic hepatitis. Symptoms include changes I appetite, dry mouth, yellowing of skin or eyes, weight loss, fever and fatigue. Sometime alcoholic hepatitis could get serious conditions include fluid buildup in the abdomen, confusion or brain fog and bleeding in esophagus or stomach. Treatment for alcoholic hepatitis involves therapies and drinking cessation to ease the sign and symptoms of liver damage. Corticosteroids are the current main treatment for alcoholic hepatitis in patients who do not have contraindication for steroid treatment. Corticosteroids are the medications have shown short-term benefits in increasing survival of certain people suffer with alcoholic hepatitis. Pentoxifylline is recommend to patients who can’t take corticosteroids. Studies indicate that pentoxifylline might not be effective for people with mild alcoholic hepatitis or people who have not respond to steroid treatment.
LPI (LP Information)' newest research report, the “Alcoholic Hepatitis Therapeutic Industry Forecast” looks at past sales and reviews total world Alcoholic Hepatitis Therapeutic sales in 2022, providing a comprehensive analysis by region and market sector of projected Alcoholic Hepatitis Therapeutic sales for 2023 through 2029. With Alcoholic Hepatitis Therapeutic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Alcoholic Hepatitis Therapeutic industry.
This Insight Report provides a comprehensive analysis of the global Alcoholic Hepatitis Therapeutic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Alcoholic Hepatitis Therapeutic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Alcoholic Hepatitis Therapeutic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Alcoholic Hepatitis Therapeutic and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Alcoholic Hepatitis Therapeutic.
The global Alcoholic Hepatitis Therapeutic market size is projected to grow from US$ 2608.5 million in 2022 to US$ 3781.1 million in 2029; it is expected to grow at a CAGR of 5.4% from 2023 to 2029.
The global alcoholic hepatitis therapeutics market is expected to witness a favorable growth during the forecast period. Increasing incidence of liver diseases and high success rate of pipeline drugs are the major factors which increase global alcoholic hepatitis market. Moreover high adoption rate for novel therapeutic products and increasing prevalence of alcoholic liver disease are some other factors that are expected to fuel the demand of global alcoholic hepatitis market. Global alcoholic hepatitis market shows potential to be expanding and lucrative field due to increasing merger and acquisitions among pharmaceutical companies to develop advance therapies for treating liver diseases. Furthermore, increased focus on retaining best quality of life is one the factor contributing to the growth of the market. However increasing health care expenditure, stringent reimbursement policies and high development cost are some factors that might hinder the growth of alcoholic hepatitis therapeutics market in forecast period.
This report presents a comprehensive overview, market shares, and growth opportunities of Alcoholic Hepatitis Therapeutic market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Monoclonal Antibodies
- Caspase Protease Inhibitor
- Corticosteroids
- Hemorheologic Agents
- Anabolic Steroids
- Hepatotropic Hormones
- Sulfhydryl Agents
- Others
- Hospitals and Clinics
- Research and Development
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Alkermes
- Conatus pharmaceuticals
- Dainippon sumitomo pharma
- Generon corporation
- Immuron limited
- Lupin Laboratories
- Intercept Pharmaceuticals
- Teva Pharmaceuticals
- Sanofi-Aventis
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Alcoholic Hepatitis Therapeutic Market Size 2018-2029
2.1.2 Alcoholic Hepatitis Therapeutic Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Alcoholic Hepatitis Therapeutic Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Caspase Protease Inhibitor
2.2.3 Corticosteroids
2.2.4 Hemorheologic Agents
2.2.5 Anabolic Steroids
2.2.6 Hepatotropic Hormones
2.2.7 Sulfhydryl Agents
2.2.8 Others
2.3 Alcoholic Hepatitis Therapeutic Market Size by Type
2.3.1 Alcoholic Hepatitis Therapeutic Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Alcoholic Hepatitis Therapeutic Market Size Market Share by Type (2018-2023)
2.4 Alcoholic Hepatitis Therapeutic Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Research and Development
2.5 Alcoholic Hepatitis Therapeutic Market Size by Application
2.5.1 Alcoholic Hepatitis Therapeutic Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Alcoholic Hepatitis Therapeutic Market Size Market Share by Application (2018-2023)
3 ALCOHOLIC HEPATITIS THERAPEUTIC MARKET SIZE BY PLAYER
3.1 Alcoholic Hepatitis Therapeutic Market Size Market Share by Players
3.1.1 Global Alcoholic Hepatitis Therapeutic Revenue by Players (2018-2023)
3.1.2 Global Alcoholic Hepatitis Therapeutic Revenue Market Share by Players (2018-2023)
3.2 Global Alcoholic Hepatitis Therapeutic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ALCOHOLIC HEPATITIS THERAPEUTIC BY REGIONS
4.1 Alcoholic Hepatitis Therapeutic Market Size by Regions (2018-2023)
4.2 Americas Alcoholic Hepatitis Therapeutic Market Size Growth (2018-2023)
4.3 APAC Alcoholic Hepatitis Therapeutic Market Size Growth (2018-2023)
4.4 Europe Alcoholic Hepatitis Therapeutic Market Size Growth (2018-2023)
4.5 Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Alcoholic Hepatitis Therapeutic Market Size by Country (2018-2023)
5.2 Americas Alcoholic Hepatitis Therapeutic Market Size by Type (2018-2023)
5.3 Americas Alcoholic Hepatitis Therapeutic Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Alcoholic Hepatitis Therapeutic Market Size by Region (2018-2023)
6.2 APAC Alcoholic Hepatitis Therapeutic Market Size by Type (2018-2023)
6.3 APAC Alcoholic Hepatitis Therapeutic Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Alcoholic Hepatitis Therapeutic by Country (2018-2023)
7.2 Europe Alcoholic Hepatitis Therapeutic Market Size by Type (2018-2023)
7.3 Europe Alcoholic Hepatitis Therapeutic Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Alcoholic Hepatitis Therapeutic by Region (2018-2023)
8.2 Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Type (2018-2023)
8.3 Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ALCOHOLIC HEPATITIS THERAPEUTIC MARKET FORECAST
10.1 Global Alcoholic Hepatitis Therapeutic Forecast by Regions (2024-2029)
10.1.1 Global Alcoholic Hepatitis Therapeutic Forecast by Regions (2024-2029)
10.1.2 Americas Alcoholic Hepatitis Therapeutic Forecast
10.1.3 APAC Alcoholic Hepatitis Therapeutic Forecast
10.1.4 Europe Alcoholic Hepatitis Therapeutic Forecast
10.1.5 Middle East & Africa Alcoholic Hepatitis Therapeutic Forecast
10.2 Americas Alcoholic Hepatitis Therapeutic Forecast by Country (2024-2029)
10.2.1 United States Alcoholic Hepatitis Therapeutic Market Forecast
10.2.2 Canada Alcoholic Hepatitis Therapeutic Market Forecast
10.2.3 Mexico Alcoholic Hepatitis Therapeutic Market Forecast
10.2.4 Brazil Alcoholic Hepatitis Therapeutic Market Forecast
10.3 APAC Alcoholic Hepatitis Therapeutic Forecast by Region (2024-2029)
10.3.1 China Alcoholic Hepatitis Therapeutic Market Forecast
10.3.2 Japan Alcoholic Hepatitis Therapeutic Market Forecast
10.3.3 Korea Alcoholic Hepatitis Therapeutic Market Forecast
10.3.4 Southeast Asia Alcoholic Hepatitis Therapeutic Market Forecast
10.3.5 India Alcoholic Hepatitis Therapeutic Market Forecast
10.3.6 Australia Alcoholic Hepatitis Therapeutic Market Forecast
10.4 Europe Alcoholic Hepatitis Therapeutic Forecast by Country (2024-2029)
10.4.1 Germany Alcoholic Hepatitis Therapeutic Market Forecast
10.4.2 France Alcoholic Hepatitis Therapeutic Market Forecast
10.4.3 UK Alcoholic Hepatitis Therapeutic Market Forecast
10.4.4 Italy Alcoholic Hepatitis Therapeutic Market Forecast
10.4.5 Russia Alcoholic Hepatitis Therapeutic Market Forecast
10.5 Middle East & Africa Alcoholic Hepatitis Therapeutic Forecast by Region (2024-2029)
10.5.1 Egypt Alcoholic Hepatitis Therapeutic Market Forecast
10.5.2 South Africa Alcoholic Hepatitis Therapeutic Market Forecast
10.5.3 Israel Alcoholic Hepatitis Therapeutic Market Forecast
10.5.4 Turkey Alcoholic Hepatitis Therapeutic Market Forecast
10.5.5 GCC Countries Alcoholic Hepatitis Therapeutic Market Forecast
10.6 Global Alcoholic Hepatitis Therapeutic Forecast by Type (2024-2029)
10.7 Global Alcoholic Hepatitis Therapeutic Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Alkermes
11.1.1 Alkermes Company Information
11.1.2 Alkermes Alcoholic Hepatitis Therapeutic Product Offered
11.1.3 Alkermes Alcoholic Hepatitis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Alkermes Main Business Overview
11.1.5 Alkermes Latest Developments
11.2 Conatus pharmaceuticals
11.2.1 Conatus pharmaceuticals Company Information
11.2.2 Conatus pharmaceuticals Alcoholic Hepatitis Therapeutic Product Offered
11.2.3 Conatus pharmaceuticals Alcoholic Hepatitis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Conatus pharmaceuticals Main Business Overview
11.2.5 Conatus pharmaceuticals Latest Developments
11.3 Dainippon sumitomo pharma
11.3.1 Dainippon sumitomo pharma Company Information
11.3.2 Dainippon sumitomo pharma Alcoholic Hepatitis Therapeutic Product Offered
11.3.3 Dainippon sumitomo pharma Alcoholic Hepatitis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Dainippon sumitomo pharma Main Business Overview
11.3.5 Dainippon sumitomo pharma Latest Developments
11.4 Generon corporation
11.4.1 Generon corporation Company Information
11.4.2 Generon corporation Alcoholic Hepatitis Therapeutic Product Offered
11.4.3 Generon corporation Alcoholic Hepatitis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Generon corporation Main Business Overview
11.4.5 Generon corporation Latest Developments
11.5 Immuron limited
11.5.1 Immuron limited Company Information
11.5.2 Immuron limited Alcoholic Hepatitis Therapeutic Product Offered
11.5.3 Immuron limited Alcoholic Hepatitis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Immuron limited Main Business Overview
11.5.5 Immuron limited Latest Developments
11.6 Lupin Laboratories
11.6.1 Lupin Laboratories Company Information
11.6.2 Lupin Laboratories Alcoholic Hepatitis Therapeutic Product Offered
11.6.3 Lupin Laboratories Alcoholic Hepatitis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Lupin Laboratories Main Business Overview
11.6.5 Lupin Laboratories Latest Developments
11.7 Intercept Pharmaceuticals
11.7.1 Intercept Pharmaceuticals Company Information
11.7.2 Intercept Pharmaceuticals Alcoholic Hepatitis Therapeutic Product Offered
11.7.3 Intercept Pharmaceuticals Alcoholic Hepatitis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Intercept Pharmaceuticals Main Business Overview
11.7.5 Intercept Pharmaceuticals Latest Developments
11.8 Teva Pharmaceuticals
11.8.1 Teva Pharmaceuticals Company Information
11.8.2 Teva Pharmaceuticals Alcoholic Hepatitis Therapeutic Product Offered
11.8.3 Teva Pharmaceuticals Alcoholic Hepatitis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Teva Pharmaceuticals Main Business Overview
11.8.5 Teva Pharmaceuticals Latest Developments
11.9 Sanofi-Aventis
11.9.1 Sanofi-Aventis Company Information
11.9.2 Sanofi-Aventis Alcoholic Hepatitis Therapeutic Product Offered
11.9.3 Sanofi-Aventis Alcoholic Hepatitis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Sanofi-Aventis Main Business Overview
11.9.5 Sanofi-Aventis Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Alcoholic Hepatitis Therapeutic Market Size 2018-2029
2.1.2 Alcoholic Hepatitis Therapeutic Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Alcoholic Hepatitis Therapeutic Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Caspase Protease Inhibitor
2.2.3 Corticosteroids
2.2.4 Hemorheologic Agents
2.2.5 Anabolic Steroids
2.2.6 Hepatotropic Hormones
2.2.7 Sulfhydryl Agents
2.2.8 Others
2.3 Alcoholic Hepatitis Therapeutic Market Size by Type
2.3.1 Alcoholic Hepatitis Therapeutic Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Alcoholic Hepatitis Therapeutic Market Size Market Share by Type (2018-2023)
2.4 Alcoholic Hepatitis Therapeutic Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Research and Development
2.5 Alcoholic Hepatitis Therapeutic Market Size by Application
2.5.1 Alcoholic Hepatitis Therapeutic Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Alcoholic Hepatitis Therapeutic Market Size Market Share by Application (2018-2023)
3 ALCOHOLIC HEPATITIS THERAPEUTIC MARKET SIZE BY PLAYER
3.1 Alcoholic Hepatitis Therapeutic Market Size Market Share by Players
3.1.1 Global Alcoholic Hepatitis Therapeutic Revenue by Players (2018-2023)
3.1.2 Global Alcoholic Hepatitis Therapeutic Revenue Market Share by Players (2018-2023)
3.2 Global Alcoholic Hepatitis Therapeutic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ALCOHOLIC HEPATITIS THERAPEUTIC BY REGIONS
4.1 Alcoholic Hepatitis Therapeutic Market Size by Regions (2018-2023)
4.2 Americas Alcoholic Hepatitis Therapeutic Market Size Growth (2018-2023)
4.3 APAC Alcoholic Hepatitis Therapeutic Market Size Growth (2018-2023)
4.4 Europe Alcoholic Hepatitis Therapeutic Market Size Growth (2018-2023)
4.5 Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Alcoholic Hepatitis Therapeutic Market Size by Country (2018-2023)
5.2 Americas Alcoholic Hepatitis Therapeutic Market Size by Type (2018-2023)
5.3 Americas Alcoholic Hepatitis Therapeutic Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Alcoholic Hepatitis Therapeutic Market Size by Region (2018-2023)
6.2 APAC Alcoholic Hepatitis Therapeutic Market Size by Type (2018-2023)
6.3 APAC Alcoholic Hepatitis Therapeutic Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Alcoholic Hepatitis Therapeutic by Country (2018-2023)
7.2 Europe Alcoholic Hepatitis Therapeutic Market Size by Type (2018-2023)
7.3 Europe Alcoholic Hepatitis Therapeutic Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Alcoholic Hepatitis Therapeutic by Region (2018-2023)
8.2 Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Type (2018-2023)
8.3 Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ALCOHOLIC HEPATITIS THERAPEUTIC MARKET FORECAST
10.1 Global Alcoholic Hepatitis Therapeutic Forecast by Regions (2024-2029)
10.1.1 Global Alcoholic Hepatitis Therapeutic Forecast by Regions (2024-2029)
10.1.2 Americas Alcoholic Hepatitis Therapeutic Forecast
10.1.3 APAC Alcoholic Hepatitis Therapeutic Forecast
10.1.4 Europe Alcoholic Hepatitis Therapeutic Forecast
10.1.5 Middle East & Africa Alcoholic Hepatitis Therapeutic Forecast
10.2 Americas Alcoholic Hepatitis Therapeutic Forecast by Country (2024-2029)
10.2.1 United States Alcoholic Hepatitis Therapeutic Market Forecast
10.2.2 Canada Alcoholic Hepatitis Therapeutic Market Forecast
10.2.3 Mexico Alcoholic Hepatitis Therapeutic Market Forecast
10.2.4 Brazil Alcoholic Hepatitis Therapeutic Market Forecast
10.3 APAC Alcoholic Hepatitis Therapeutic Forecast by Region (2024-2029)
10.3.1 China Alcoholic Hepatitis Therapeutic Market Forecast
10.3.2 Japan Alcoholic Hepatitis Therapeutic Market Forecast
10.3.3 Korea Alcoholic Hepatitis Therapeutic Market Forecast
10.3.4 Southeast Asia Alcoholic Hepatitis Therapeutic Market Forecast
10.3.5 India Alcoholic Hepatitis Therapeutic Market Forecast
10.3.6 Australia Alcoholic Hepatitis Therapeutic Market Forecast
10.4 Europe Alcoholic Hepatitis Therapeutic Forecast by Country (2024-2029)
10.4.1 Germany Alcoholic Hepatitis Therapeutic Market Forecast
10.4.2 France Alcoholic Hepatitis Therapeutic Market Forecast
10.4.3 UK Alcoholic Hepatitis Therapeutic Market Forecast
10.4.4 Italy Alcoholic Hepatitis Therapeutic Market Forecast
10.4.5 Russia Alcoholic Hepatitis Therapeutic Market Forecast
10.5 Middle East & Africa Alcoholic Hepatitis Therapeutic Forecast by Region (2024-2029)
10.5.1 Egypt Alcoholic Hepatitis Therapeutic Market Forecast
10.5.2 South Africa Alcoholic Hepatitis Therapeutic Market Forecast
10.5.3 Israel Alcoholic Hepatitis Therapeutic Market Forecast
10.5.4 Turkey Alcoholic Hepatitis Therapeutic Market Forecast
10.5.5 GCC Countries Alcoholic Hepatitis Therapeutic Market Forecast
10.6 Global Alcoholic Hepatitis Therapeutic Forecast by Type (2024-2029)
10.7 Global Alcoholic Hepatitis Therapeutic Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Alkermes
11.1.1 Alkermes Company Information
11.1.2 Alkermes Alcoholic Hepatitis Therapeutic Product Offered
11.1.3 Alkermes Alcoholic Hepatitis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Alkermes Main Business Overview
11.1.5 Alkermes Latest Developments
11.2 Conatus pharmaceuticals
11.2.1 Conatus pharmaceuticals Company Information
11.2.2 Conatus pharmaceuticals Alcoholic Hepatitis Therapeutic Product Offered
11.2.3 Conatus pharmaceuticals Alcoholic Hepatitis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Conatus pharmaceuticals Main Business Overview
11.2.5 Conatus pharmaceuticals Latest Developments
11.3 Dainippon sumitomo pharma
11.3.1 Dainippon sumitomo pharma Company Information
11.3.2 Dainippon sumitomo pharma Alcoholic Hepatitis Therapeutic Product Offered
11.3.3 Dainippon sumitomo pharma Alcoholic Hepatitis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Dainippon sumitomo pharma Main Business Overview
11.3.5 Dainippon sumitomo pharma Latest Developments
11.4 Generon corporation
11.4.1 Generon corporation Company Information
11.4.2 Generon corporation Alcoholic Hepatitis Therapeutic Product Offered
11.4.3 Generon corporation Alcoholic Hepatitis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Generon corporation Main Business Overview
11.4.5 Generon corporation Latest Developments
11.5 Immuron limited
11.5.1 Immuron limited Company Information
11.5.2 Immuron limited Alcoholic Hepatitis Therapeutic Product Offered
11.5.3 Immuron limited Alcoholic Hepatitis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Immuron limited Main Business Overview
11.5.5 Immuron limited Latest Developments
11.6 Lupin Laboratories
11.6.1 Lupin Laboratories Company Information
11.6.2 Lupin Laboratories Alcoholic Hepatitis Therapeutic Product Offered
11.6.3 Lupin Laboratories Alcoholic Hepatitis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Lupin Laboratories Main Business Overview
11.6.5 Lupin Laboratories Latest Developments
11.7 Intercept Pharmaceuticals
11.7.1 Intercept Pharmaceuticals Company Information
11.7.2 Intercept Pharmaceuticals Alcoholic Hepatitis Therapeutic Product Offered
11.7.3 Intercept Pharmaceuticals Alcoholic Hepatitis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Intercept Pharmaceuticals Main Business Overview
11.7.5 Intercept Pharmaceuticals Latest Developments
11.8 Teva Pharmaceuticals
11.8.1 Teva Pharmaceuticals Company Information
11.8.2 Teva Pharmaceuticals Alcoholic Hepatitis Therapeutic Product Offered
11.8.3 Teva Pharmaceuticals Alcoholic Hepatitis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Teva Pharmaceuticals Main Business Overview
11.8.5 Teva Pharmaceuticals Latest Developments
11.9 Sanofi-Aventis
11.9.1 Sanofi-Aventis Company Information
11.9.2 Sanofi-Aventis Alcoholic Hepatitis Therapeutic Product Offered
11.9.3 Sanofi-Aventis Alcoholic Hepatitis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Sanofi-Aventis Main Business Overview
11.9.5 Sanofi-Aventis Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Alcoholic Hepatitis Therapeutic Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Monoclonal Antibodies
Table 3. Major Players of Caspase Protease Inhibitor
Table 4. Major Players of Corticosteroids
Table 5. Major Players of Hemorheologic Agents
Table 6. Major Players of Anabolic Steroids
Table 7. Major Players of Hepatotropic Hormones
Table 8. Major Players of Sulfhydryl Agents
Table 9. Major Players of Others
Table 10. Alcoholic Hepatitis Therapeutic Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 11. Global Alcoholic Hepatitis Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 12. Global Alcoholic Hepatitis Therapeutic Market Size Market Share by Type (2018-2023)
Table 13. Alcoholic Hepatitis Therapeutic Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 14. Global Alcoholic Hepatitis Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 15. Global Alcoholic Hepatitis Therapeutic Market Size Market Share by Application (2018-2023)
Table 16. Global Alcoholic Hepatitis Therapeutic Revenue by Players (2018-2023) & ($ Millions)
Table 17. Global Alcoholic Hepatitis Therapeutic Revenue Market Share by Player (2018-2023)
Table 18. Alcoholic Hepatitis Therapeutic Key Players Head office and Products Offered
Table 19. Alcoholic Hepatitis Therapeutic Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global Alcoholic Hepatitis Therapeutic Market Size by Regions 2018-2023 & ($ Millions)
Table 23. Global Alcoholic Hepatitis Therapeutic Market Size Market Share by Regions (2018-2023)
Table 24. Global Alcoholic Hepatitis Therapeutic Revenue by Country/Region (2018-2023) & ($ millions)
Table 25. Global Alcoholic Hepatitis Therapeutic Revenue Market Share by Country/Region (2018-2023)
Table 26. Americas Alcoholic Hepatitis Therapeutic Market Size by Country (2018-2023) & ($ Millions)
Table 27. Americas Alcoholic Hepatitis Therapeutic Market Size Market Share by Country (2018-2023)
Table 28. Americas Alcoholic Hepatitis Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 29. Americas Alcoholic Hepatitis Therapeutic Market Size Market Share by Type (2018-2023)
Table 30. Americas Alcoholic Hepatitis Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 31. Americas Alcoholic Hepatitis Therapeutic Market Size Market Share by Application (2018-2023)
Table 32. APAC Alcoholic Hepatitis Therapeutic Market Size by Region (2018-2023) & ($ Millions)
Table 33. APAC Alcoholic Hepatitis Therapeutic Market Size Market Share by Region (2018-2023)
Table 34. APAC Alcoholic Hepatitis Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 35. APAC Alcoholic Hepatitis Therapeutic Market Size Market Share by Type (2018-2023)
Table 36. APAC Alcoholic Hepatitis Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 37. APAC Alcoholic Hepatitis Therapeutic Market Size Market Share by Application (2018-2023)
Table 38. Europe Alcoholic Hepatitis Therapeutic Market Size by Country (2018-2023) & ($ Millions)
Table 39. Europe Alcoholic Hepatitis Therapeutic Market Size Market Share by Country (2018-2023)
Table 40. Europe Alcoholic Hepatitis Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 41. Europe Alcoholic Hepatitis Therapeutic Market Size Market Share by Type (2018-2023)
Table 42. Europe Alcoholic Hepatitis Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 43. Europe Alcoholic Hepatitis Therapeutic Market Size Market Share by Application (2018-2023)
Table 44. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Region (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size Market Share by Region (2018-2023)
Table 46. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 47. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size Market Share by Type (2018-2023)
Table 48. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 49. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size Market Share by Application (2018-2023)
Table 50. Key Market Drivers & Growth Opportunities of Alcoholic Hepatitis Therapeutic
Table 51. Key Market Challenges & Risks of Alcoholic Hepatitis Therapeutic
Table 52. Key Industry Trends of Alcoholic Hepatitis Therapeutic
Table 53. Global Alcoholic Hepatitis Therapeutic Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 54. Global Alcoholic Hepatitis Therapeutic Market Size Market Share Forecast by Regions (2024-2029)
Table 55. Global Alcoholic Hepatitis Therapeutic Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 56. Global Alcoholic Hepatitis Therapeutic Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 57. Alkermes Details, Company Type, Alcoholic Hepatitis Therapeutic Area Served and Its Competitors
Table 58. Alkermes Alcoholic Hepatitis Therapeutic Product Offered
Table 59. Alkermes Alcoholic Hepatitis Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Alkermes Main Business
Table 61. Alkermes Latest Developments
Table 62. Conatus pharmaceuticals Details, Company Type, Alcoholic Hepatitis Therapeutic Area Served and Its Competitors
Table 63. Conatus pharmaceuticals Alcoholic Hepatitis Therapeutic Product Offered
Table 64. Conatus pharmaceuticals Main Business
Table 65. Conatus pharmaceuticals Alcoholic Hepatitis Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Conatus pharmaceuticals Latest Developments
Table 67. Dainippon sumitomo pharma Details, Company Type, Alcoholic Hepatitis Therapeutic Area Served and Its Competitors
Table 68. Dainippon sumitomo pharma Alcoholic Hepatitis Therapeutic Product Offered
Table 69. Dainippon sumitomo pharma Main Business
Table 70. Dainippon sumitomo pharma Alcoholic Hepatitis Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Dainippon sumitomo pharma Latest Developments
Table 72. Generon corporation Details, Company Type, Alcoholic Hepatitis Therapeutic Area Served and Its Competitors
Table 73. Generon corporation Alcoholic Hepatitis Therapeutic Product Offered
Table 74. Generon corporation Main Business
Table 75. Generon corporation Alcoholic Hepatitis Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Generon corporation Latest Developments
Table 77. Immuron limited Details, Company Type, Alcoholic Hepatitis Therapeutic Area Served and Its Competitors
Table 78. Immuron limited Alcoholic Hepatitis Therapeutic Product Offered
Table 79. Immuron limited Main Business
Table 80. Immuron limited Alcoholic Hepatitis Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Immuron limited Latest Developments
Table 82. Lupin Laboratories Details, Company Type, Alcoholic Hepatitis Therapeutic Area Served and Its Competitors
Table 83. Lupin Laboratories Alcoholic Hepatitis Therapeutic Product Offered
Table 84. Lupin Laboratories Main Business
Table 85. Lupin Laboratories Alcoholic Hepatitis Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Lupin Laboratories Latest Developments
Table 87. Intercept Pharmaceuticals Details, Company Type, Alcoholic Hepatitis Therapeutic Area Served and Its Competitors
Table 88. Intercept Pharmaceuticals Alcoholic Hepatitis Therapeutic Product Offered
Table 89. Intercept Pharmaceuticals Main Business
Table 90. Intercept Pharmaceuticals Alcoholic Hepatitis Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Intercept Pharmaceuticals Latest Developments
Table 92. Teva Pharmaceuticals Details, Company Type, Alcoholic Hepatitis Therapeutic Area Served and Its Competitors
Table 93. Teva Pharmaceuticals Alcoholic Hepatitis Therapeutic Product Offered
Table 94. Teva Pharmaceuticals Main Business
Table 95. Teva Pharmaceuticals Alcoholic Hepatitis Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Teva Pharmaceuticals Latest Developments
Table 97. Sanofi-Aventis Details, Company Type, Alcoholic Hepatitis Therapeutic Area Served and Its Competitors
Table 98. Sanofi-Aventis Alcoholic Hepatitis Therapeutic Product Offered
Table 99. Sanofi-Aventis Main Business
Table 100. Sanofi-Aventis Alcoholic Hepatitis Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Sanofi-Aventis Latest Developments
Table 1. Alcoholic Hepatitis Therapeutic Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Monoclonal Antibodies
Table 3. Major Players of Caspase Protease Inhibitor
Table 4. Major Players of Corticosteroids
Table 5. Major Players of Hemorheologic Agents
Table 6. Major Players of Anabolic Steroids
Table 7. Major Players of Hepatotropic Hormones
Table 8. Major Players of Sulfhydryl Agents
Table 9. Major Players of Others
Table 10. Alcoholic Hepatitis Therapeutic Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 11. Global Alcoholic Hepatitis Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 12. Global Alcoholic Hepatitis Therapeutic Market Size Market Share by Type (2018-2023)
Table 13. Alcoholic Hepatitis Therapeutic Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 14. Global Alcoholic Hepatitis Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 15. Global Alcoholic Hepatitis Therapeutic Market Size Market Share by Application (2018-2023)
Table 16. Global Alcoholic Hepatitis Therapeutic Revenue by Players (2018-2023) & ($ Millions)
Table 17. Global Alcoholic Hepatitis Therapeutic Revenue Market Share by Player (2018-2023)
Table 18. Alcoholic Hepatitis Therapeutic Key Players Head office and Products Offered
Table 19. Alcoholic Hepatitis Therapeutic Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global Alcoholic Hepatitis Therapeutic Market Size by Regions 2018-2023 & ($ Millions)
Table 23. Global Alcoholic Hepatitis Therapeutic Market Size Market Share by Regions (2018-2023)
Table 24. Global Alcoholic Hepatitis Therapeutic Revenue by Country/Region (2018-2023) & ($ millions)
Table 25. Global Alcoholic Hepatitis Therapeutic Revenue Market Share by Country/Region (2018-2023)
Table 26. Americas Alcoholic Hepatitis Therapeutic Market Size by Country (2018-2023) & ($ Millions)
Table 27. Americas Alcoholic Hepatitis Therapeutic Market Size Market Share by Country (2018-2023)
Table 28. Americas Alcoholic Hepatitis Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 29. Americas Alcoholic Hepatitis Therapeutic Market Size Market Share by Type (2018-2023)
Table 30. Americas Alcoholic Hepatitis Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 31. Americas Alcoholic Hepatitis Therapeutic Market Size Market Share by Application (2018-2023)
Table 32. APAC Alcoholic Hepatitis Therapeutic Market Size by Region (2018-2023) & ($ Millions)
Table 33. APAC Alcoholic Hepatitis Therapeutic Market Size Market Share by Region (2018-2023)
Table 34. APAC Alcoholic Hepatitis Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 35. APAC Alcoholic Hepatitis Therapeutic Market Size Market Share by Type (2018-2023)
Table 36. APAC Alcoholic Hepatitis Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 37. APAC Alcoholic Hepatitis Therapeutic Market Size Market Share by Application (2018-2023)
Table 38. Europe Alcoholic Hepatitis Therapeutic Market Size by Country (2018-2023) & ($ Millions)
Table 39. Europe Alcoholic Hepatitis Therapeutic Market Size Market Share by Country (2018-2023)
Table 40. Europe Alcoholic Hepatitis Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 41. Europe Alcoholic Hepatitis Therapeutic Market Size Market Share by Type (2018-2023)
Table 42. Europe Alcoholic Hepatitis Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 43. Europe Alcoholic Hepatitis Therapeutic Market Size Market Share by Application (2018-2023)
Table 44. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Region (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size Market Share by Region (2018-2023)
Table 46. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 47. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size Market Share by Type (2018-2023)
Table 48. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 49. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size Market Share by Application (2018-2023)
Table 50. Key Market Drivers & Growth Opportunities of Alcoholic Hepatitis Therapeutic
Table 51. Key Market Challenges & Risks of Alcoholic Hepatitis Therapeutic
Table 52. Key Industry Trends of Alcoholic Hepatitis Therapeutic
Table 53. Global Alcoholic Hepatitis Therapeutic Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 54. Global Alcoholic Hepatitis Therapeutic Market Size Market Share Forecast by Regions (2024-2029)
Table 55. Global Alcoholic Hepatitis Therapeutic Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 56. Global Alcoholic Hepatitis Therapeutic Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 57. Alkermes Details, Company Type, Alcoholic Hepatitis Therapeutic Area Served and Its Competitors
Table 58. Alkermes Alcoholic Hepatitis Therapeutic Product Offered
Table 59. Alkermes Alcoholic Hepatitis Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Alkermes Main Business
Table 61. Alkermes Latest Developments
Table 62. Conatus pharmaceuticals Details, Company Type, Alcoholic Hepatitis Therapeutic Area Served and Its Competitors
Table 63. Conatus pharmaceuticals Alcoholic Hepatitis Therapeutic Product Offered
Table 64. Conatus pharmaceuticals Main Business
Table 65. Conatus pharmaceuticals Alcoholic Hepatitis Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Conatus pharmaceuticals Latest Developments
Table 67. Dainippon sumitomo pharma Details, Company Type, Alcoholic Hepatitis Therapeutic Area Served and Its Competitors
Table 68. Dainippon sumitomo pharma Alcoholic Hepatitis Therapeutic Product Offered
Table 69. Dainippon sumitomo pharma Main Business
Table 70. Dainippon sumitomo pharma Alcoholic Hepatitis Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Dainippon sumitomo pharma Latest Developments
Table 72. Generon corporation Details, Company Type, Alcoholic Hepatitis Therapeutic Area Served and Its Competitors
Table 73. Generon corporation Alcoholic Hepatitis Therapeutic Product Offered
Table 74. Generon corporation Main Business
Table 75. Generon corporation Alcoholic Hepatitis Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Generon corporation Latest Developments
Table 77. Immuron limited Details, Company Type, Alcoholic Hepatitis Therapeutic Area Served and Its Competitors
Table 78. Immuron limited Alcoholic Hepatitis Therapeutic Product Offered
Table 79. Immuron limited Main Business
Table 80. Immuron limited Alcoholic Hepatitis Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Immuron limited Latest Developments
Table 82. Lupin Laboratories Details, Company Type, Alcoholic Hepatitis Therapeutic Area Served and Its Competitors
Table 83. Lupin Laboratories Alcoholic Hepatitis Therapeutic Product Offered
Table 84. Lupin Laboratories Main Business
Table 85. Lupin Laboratories Alcoholic Hepatitis Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Lupin Laboratories Latest Developments
Table 87. Intercept Pharmaceuticals Details, Company Type, Alcoholic Hepatitis Therapeutic Area Served and Its Competitors
Table 88. Intercept Pharmaceuticals Alcoholic Hepatitis Therapeutic Product Offered
Table 89. Intercept Pharmaceuticals Main Business
Table 90. Intercept Pharmaceuticals Alcoholic Hepatitis Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Intercept Pharmaceuticals Latest Developments
Table 92. Teva Pharmaceuticals Details, Company Type, Alcoholic Hepatitis Therapeutic Area Served and Its Competitors
Table 93. Teva Pharmaceuticals Alcoholic Hepatitis Therapeutic Product Offered
Table 94. Teva Pharmaceuticals Main Business
Table 95. Teva Pharmaceuticals Alcoholic Hepatitis Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Teva Pharmaceuticals Latest Developments
Table 97. Sanofi-Aventis Details, Company Type, Alcoholic Hepatitis Therapeutic Area Served and Its Competitors
Table 98. Sanofi-Aventis Alcoholic Hepatitis Therapeutic Product Offered
Table 99. Sanofi-Aventis Main Business
Table 100. Sanofi-Aventis Alcoholic Hepatitis Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Sanofi-Aventis Latest Developments
LIST OF FIGURES
Figure 1. Alcoholic Hepatitis Therapeutic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Alcoholic Hepatitis Therapeutic Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Alcoholic Hepatitis Therapeutic Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Alcoholic Hepatitis Therapeutic Sales Market Share by Country/Region (2022)
Figure 8. Alcoholic Hepatitis Therapeutic Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Alcoholic Hepatitis Therapeutic Market Size Market Share by Type in 2022
Figure 10. Alcoholic Hepatitis Therapeutic in Hospitals and Clinics
Figure 11. Global Alcoholic Hepatitis Therapeutic Market: Hospitals and Clinics (2018-2023) & ($ Millions)
Figure 12. Alcoholic Hepatitis Therapeutic in Research and Development
Figure 13. Global Alcoholic Hepatitis Therapeutic Market: Research and Development (2018-2023) & ($ Millions)
Figure 14. Global Alcoholic Hepatitis Therapeutic Market Size Market Share by Application in 2022
Figure 15. Global Alcoholic Hepatitis Therapeutic Revenue Market Share by Player in 2022
Figure 16. Global Alcoholic Hepatitis Therapeutic Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Alcoholic Hepatitis Therapeutic Market Size 2018-2023 ($ Millions)
Figure 18. APAC Alcoholic Hepatitis Therapeutic Market Size 2018-2023 ($ Millions)
Figure 19. Europe Alcoholic Hepatitis Therapeutic Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size 2018-2023 ($ Millions)
Figure 21. Americas Alcoholic Hepatitis Therapeutic Value Market Share by Country in 2022
Figure 22. United States Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Alcoholic Hepatitis Therapeutic Market Size Market Share by Region in 2022
Figure 27. APAC Alcoholic Hepatitis Therapeutic Market Size Market Share by Type in 2022
Figure 28. APAC Alcoholic Hepatitis Therapeutic Market Size Market Share by Application in 2022
Figure 29. China Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Alcoholic Hepatitis Therapeutic Market Size Market Share by Country in 2022
Figure 36. Europe Alcoholic Hepatitis Therapeutic Market Size Market Share by Type (2018-2023)
Figure 37. Europe Alcoholic Hepatitis Therapeutic Market Size Market Share by Application (2018-2023)
Figure 38. Germany Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 52. APAC Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 53. Europe Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 55. United States Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 56. Canada Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 59. China Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 60. Japan Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 61. Korea Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 63. India Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 64. Australia Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 65. Germany Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 66. France Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 67. UK Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 68. Italy Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 69. Russia Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 70. Spain Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 73. Israel Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 76. Global Alcoholic Hepatitis Therapeutic Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Alcoholic Hepatitis Therapeutic Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Alcoholic Hepatitis Therapeutic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Alcoholic Hepatitis Therapeutic Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Alcoholic Hepatitis Therapeutic Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Alcoholic Hepatitis Therapeutic Sales Market Share by Country/Region (2022)
Figure 8. Alcoholic Hepatitis Therapeutic Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Alcoholic Hepatitis Therapeutic Market Size Market Share by Type in 2022
Figure 10. Alcoholic Hepatitis Therapeutic in Hospitals and Clinics
Figure 11. Global Alcoholic Hepatitis Therapeutic Market: Hospitals and Clinics (2018-2023) & ($ Millions)
Figure 12. Alcoholic Hepatitis Therapeutic in Research and Development
Figure 13. Global Alcoholic Hepatitis Therapeutic Market: Research and Development (2018-2023) & ($ Millions)
Figure 14. Global Alcoholic Hepatitis Therapeutic Market Size Market Share by Application in 2022
Figure 15. Global Alcoholic Hepatitis Therapeutic Revenue Market Share by Player in 2022
Figure 16. Global Alcoholic Hepatitis Therapeutic Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Alcoholic Hepatitis Therapeutic Market Size 2018-2023 ($ Millions)
Figure 18. APAC Alcoholic Hepatitis Therapeutic Market Size 2018-2023 ($ Millions)
Figure 19. Europe Alcoholic Hepatitis Therapeutic Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size 2018-2023 ($ Millions)
Figure 21. Americas Alcoholic Hepatitis Therapeutic Value Market Share by Country in 2022
Figure 22. United States Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Alcoholic Hepatitis Therapeutic Market Size Market Share by Region in 2022
Figure 27. APAC Alcoholic Hepatitis Therapeutic Market Size Market Share by Type in 2022
Figure 28. APAC Alcoholic Hepatitis Therapeutic Market Size Market Share by Application in 2022
Figure 29. China Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Alcoholic Hepatitis Therapeutic Market Size Market Share by Country in 2022
Figure 36. Europe Alcoholic Hepatitis Therapeutic Market Size Market Share by Type (2018-2023)
Figure 37. Europe Alcoholic Hepatitis Therapeutic Market Size Market Share by Application (2018-2023)
Figure 38. Germany Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Alcoholic Hepatitis Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 52. APAC Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 53. Europe Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 55. United States Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 56. Canada Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 59. China Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 60. Japan Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 61. Korea Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 63. India Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 64. Australia Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 65. Germany Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 66. France Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 67. UK Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 68. Italy Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 69. Russia Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 70. Spain Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 73. Israel Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Alcoholic Hepatitis Therapeutic Market Size 2024-2029 ($ Millions)
Figure 76. Global Alcoholic Hepatitis Therapeutic Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Alcoholic Hepatitis Therapeutic Market Size Market Share Forecast by Application (2024-2029)
